Publication Results

Generate Report

Add publications by marking their checkboxes, or

Metabolite Profiles of Incident Diabetes and Heterogeneity of Treatment Effect in the Diabetes Prevention Program.

Chen ZZ,  Liu J,  Morningstar J,  Heckman-Stoddard BM,  Lee CG,  Dagogo-Jack S,  Ferguson JF,  Hamman RF,  Knowler WC,  Mather KJ,  Perreault L,  Florez JC,  Wang TJ,  Clish C,  Temprosa M,  Gerszten RE,  Diabetes Prevention Program Research Group
Diabetes 2019 Dec;68(12):2337-2349
Major Program(s) or Research Group(s): Breast and Gynecologic Cancer
PubMed ID: 31582408
PMC ID: PMC6868469 [available on December 01, 2020]

A Randomized, Placebo-Controlled, Double-Blind, Dose Escalation, Single Dose, and Steady-State Pharmacokinetic Study of 9cUAB30 in Healthy Volunteers.

Kolesar JM,  Andrews S,  Green H,  Havighurst TC,  Wollmer BW,  DeShong K,  Laux DE,  Krontiras H,  Muccio DD,  Kim K,  Grubbs CJ,  House MG,  Parnes HL,  Heckman-Stoddard BM,  Bailey HH
Cancer Prev Res (Phila) 2019 Dec;12(12):903-912
Major Program(s) or Research Group(s): Breast and Gynecologic CancerProstate and Urologic Cancer
PubMed ID: 31484659
PMC ID: PMC7008944

Breast Hyperplasias, Risk Signature, and Breast Cancer.

Poola I,  Yue Q,  Gillespie JW,  Sullivan PS,  Aguilar-Jakthong J,  Rao J,  Shaaban AM,  Sauter ER,  Ricci AJ
Cancer Prev Res (Phila) 2019 Jul;12(7):471-480
Major Program(s) or Research Group(s): Breast and Gynecologic Cancer
PubMed ID: 31239263
PMC ID: not available

A prospective, single-arm, open-label, non-randomized, phase IIa trial of a nonavalent prophylactic HPV vaccine to assess immunogenicity of a prime and deferred-booster dosing schedule among 9-11 year-old girls and boys - clinical protocol.

Zeng Y,  Moscicki AB,  Sahasrabuddhe VV,  Garcia F,  Woo H,  Hsu CH,  Szabo E,  Dimond E,  Vanzzini S,  Mondragon A,  Butler V,  DeRose H,  Chow HS
BMC Cancer 2019 Apr 1;19(1):290
Major Program(s) or Research Group(s): Breast and Gynecologic CancerLung and Upper Aerodigestive Cancer
PubMed ID: 30935375
PMC ID: PMC6444524

Acceptability of Localized Cancer Risk Reduction Interventions Among Individuals at Average or High Risk for Cancer.

Samimi G,  Heckman-Stoddard BM,  Kay SS,  Bloodgood B,  Coa KI,  Robinson JL,  Tennant B,  Ford LG,  Szabo E,  Minasian L
Cancer Prev Res (Phila) 2019 Apr;12(4):271-282
Major Program(s) or Research Group(s): Breast and Gynecologic CancerLung and Upper Aerodigestive Cancer ;  Office of the Director
PubMed ID: 30824471
PMC ID: PMC6445710

The Making of a PreCancer Atlas: Promises, Challenges, and Opportunities (vol 4, pg 523, 2018)

Srivastava Sudhir,  Ghosh Sharmistha,  Kagan Jacob,  Mazurchuk Richard,  Boja Emily,  Ossandon Miguel,  Chuaqui Rodrigo,  Rosenfield Sonia,  Chavarria-Johnson Eric,  Samimi Goli,  Davidsen Tanja,  Shern Jack,  Eary Janet,  Star Rob,  Haim Todd,  Takebe Naoko,  Hanlon Sean,  Tavares Norbert,  Hewitt Stephen,  Tricoli James,  Hughes Shannon,  Trimble Ted,  Jacobs Paula,  Umar Asad,  Li Jerry,  Velazquez Jose,  Lively Tracy,  Wang Chiayeng,  Lockett Stephen,  Zenklusen J. C.,  Misteli Tom,  Oberdoerffer Philipp,  Nelson Stefanie,  Lee Jerry,  Odeh Hana,  Kenney Nicholas
Trends Cancer 2019 Apr;5(4):263-263
Major Program(s) or Research Group(s): Breast and Gynecologic CancerCancer BiomarkersGastrointestinal and Other Cancers
PubMed ID: not available
PMC ID: not available

Fluoropyrimidine Cardiotoxicity: Time for a Contemporaneous Appraisal.

Upshaw JN,  O'Neill A,  Carver JR,  Dimond EP,  Denlinger CS,  Kircher SM,  Wagner LI,  Ky B,  Brell JM
Clin Colorectal Cancer 2019 Mar;18(1):44-51
Major Program(s) or Research Group(s): Breast and Gynecologic CancerNCI Community Oncology Research Program
PubMed ID: 30348619
PMC ID: PMC6927029

Concordance with BRCA1/2 testing guidelines among women in The Health of Women (HOW) Study®.

Silver MI,  Klein W,  Samimi G,  Minasian L,  Loud J,  Roberts MC
Breast Cancer Res Treat 2019 Feb;173(3):719-726
Major Program(s) or Research Group(s): Breast and Gynecologic CancerCancer Prevention Fellowship Program ;  Office of the Director
PubMed ID: 30413980
PMC ID: not available

Changing Hearts and Minds: Improving Outcomes in Cancer Treatment-Related Cardiotoxicity.

Shelburne N,  Simonds NI,  Adhikari B,  Alley M,  Desvigne-Nickens P,  Dimond E,  Filipski K,  Gallicchio L,  Minasian L
Curr Oncol Rep 2019 Jan 30;21(1):9
Major Program(s) or Research Group(s): Breast and Gynecologic Cancer ;  Office of the Director
PubMed ID: 30701318
PMC ID: not available

Comparison of 4 commercial kits for the extraction of circulating DNA from plasma.

Warton K,  Graham LJ,  Yuwono N,  Samimi G
Cancer Genet 2018 Dec;228-229:143-150
Major Program(s) or Research Group(s): Breast and Gynecologic Cancer
PubMed ID: 29567030
PMC ID: not available

A tailored approach to building specialized surgical oncology capacity: Early experiences and outcomes in Malawi.

Chinula L,  Hicks M,  Chiudzu G,  Tang JH,  Gopal S,  Tomoka T,  Kachingwe J,  Pinder L,  Hicks M,  Sahasrabuddhe V,  Parham G
Gynecol Oncol Rep 2018 Nov;26:60-65
Major Program(s) or Research Group(s): Breast and Gynecologic Cancer
PubMed ID: 30364674
PMC ID: PMC6197742

Cervico-vaginal self-collection in HIV-infected and uninfected women from Tapajós region, Amazon, Brazil: High acceptability, hrHPV diversity and risk factors.

Rodrigues LLS,  Morgado MG,  Sahasrabuddhe VV,  De Paula VS,  Oliveira NS,  Chavez-Juan E,  Da Silva DM,  Kast WM,  Nicol AF,  Pilotto JH
Gynecol Oncol 2018 Oct;151(1):102-110
Major Program(s) or Research Group(s): Breast and Gynecologic Cancer
PubMed ID: 30087059
PMC ID: PMC6151287

Leverage of an Existing Cervical Cancer Prevention Service Platform to Initiate Breast Cancer Control Services in Zambia: Experiences and Early Outcomes.

Pinder LF,  Henry-Tillman R,  Linyama D,  Kusweje V,  Nzayisenga JB,  Shibemba A,  Sahasrabuddhe V,  Lishimpi K,  Mwanahamuntu M,  Hicks M,  Parham GP
J Glob Oncol 2018 Sep;4:1-8
Major Program(s) or Research Group(s): Breast and Gynecologic Cancer
PubMed ID: 30241176
PMC ID: PMC6180756

The Making of a PreCancer Atlas: Promises, Challenges, and Opportunities.

Srivastava S,  Ghosh S,  Kagan J,  Mazurchuk R,  National Cancer Institute's HTAN Implementation
Trends Cancer 2018 Aug;4(8):523-536
Major Program(s) or Research Group(s): Breast and Gynecologic CancerCancer BiomarkersGastrointestinal and Other Cancers
PubMed ID: 30064661
PMC ID: not available

Noncommunicable diseases among HIV-infected persons in low-income and middle-income countries: a systematic review and meta-analysis.

Patel P,  Rose CE,  Collins PY,  Nuche-Berenguer B,  Sahasrabuddhe VV,  Peprah E,  Vorkoper S,  Pastakia SD,  Rausch D,  Levitt NS,  NIH HIV/NCD Project Disease Condition Technical Operating Group
AIDS 2018 Jul 1;32 Suppl 1:S5-S20
Major Program(s) or Research Group(s): Breast and Gynecologic Cancer
PubMed ID: 29952786
PMC ID: PMC6380891

Ovarian cancer statistics, 2018.

Torre LA,  Trabert B,  DeSantis CE,  Miller KD,  Samimi G,  Runowicz CD,  Gaudet MM,  Jemal A,  Siegel RL
CA Cancer J Clin 2018 Jul;68(4):284-296
Major Program(s) or Research Group(s): Breast and Gynecologic Cancer
PubMed ID: 29809280
PMC ID: PMC6621554

Is It Time to Move Beyond Visual Inspection With Acetic Acid for Cervical Cancer Screening?

Silkensen SL,  Schiffman M,  Sahasrabuddhe V,  Flanigan JS
Glob Health Sci Pract 2018 Jun 27;6(2):242-246
Major Program(s) or Research Group(s): Breast and Gynecologic Cancer
PubMed ID: 29959268
PMC ID: PMC6024629

Use of raloxifene and tamoxifen by breast cancer risk level in a Medicare-eligible cohort.

Pinsky PF,  Miller E,  Heckman-Stoddard B,  Minasian L
Am J Obstet Gynecol 2018 Jun;218(6):606.e1-606.e9
Major Program(s) or Research Group(s): Breast and Gynecologic CancerEarly Detection ;  Office of the Director
PubMed ID: 29630889
PMC ID: PMC5970073

Transducin-Like Enhancer of Split 3 (TLE3) Expression Is Associated with Taxane Sensitivity in Nonserous Ovarian Carcinoma in a Three-Cohort Study.

Ring BZ,  Murali R,  Soslow RA,  Bowtell DDL,  Fereday S,  deFazio A,  Traficante N,  Kennedy CJ,  Brand A,  Sharma R,  Harnett P,  Samimi G,  Australian Ovarian Cancer Study
Cancer Epidemiol Biomarkers Prev 2018 Jun;27(6):680-688
Major Program(s) or Research Group(s): Breast and Gynecologic Cancer
PubMed ID: 29531130
PMC ID: PMC5984690

A Randomized Multicenter Phase II Study of Docosahexaenoic Acid in Patients with a History of Breast Cancer, Premalignant Lesions, or Benign Breast Disease.

Gucalp A,  Zhou XK,  Cook ED,  Garber JE,  Crew KD,  Nangia JR,  Bhardwaj P,  Giri DD,  Elemento O,  Verma A,  Wang H,  Lee JJ,  Vornik LA,  Mays C,  Weber D,  Sepeda V,  O'Kane H,  Krasne M,  Williams S,  Morris PG,  Heckman-Stoddard BM,  Dunn BK,  Hudis CA,  Brown PH,  Dannenberg AJ
Cancer Prev Res (Phila) 2018 Apr;11(4):203-214
Major Program(s) or Research Group(s): Breast and Gynecologic CancerBiometry
PubMed ID: 29453232
PMC ID: PMC6290902

Classification and evolution of human papillomavirus genome variants: Alpha-5 (HPV26, 51, 69, 82), Alpha-6 (HPV30, 53, 56, 66), Alpha-11 (HPV34, 73), Alpha-13 (HPV54) and Alpha-3 (HPV61).

Chen Z,  Schiffman M,  Herrero R,  DeSalle R,  Anastos K,  Segondy M,  Sahasrabuddhe VV,  Gravitt PE,  Hsing AW,  Chan PKS,  Burk RD
Virology 2018 Mar;516:86-101
Major Program(s) or Research Group(s): Breast and Gynecologic Cancer
PubMed ID: 29331867
PMC ID: PMC6093212

Tissue-based Immunohistochemical Biomarker Expression in Malignant Glandular Lesions of the Uterine Cervix: A Systematic Review.

Lee S,  Sahasrabuddhe VV,  Mendoza-Cervantes D,  Zhao R,  Duggan MA
Int J Gynecol Pathol 2018 Mar;37(2):128-140
Major Program(s) or Research Group(s): Breast and Gynecologic Cancer
PubMed ID: 28582347
PMC ID: not available

Processing of fallopian tube, ovary, and endometrial surgical pathology specimens: A survey of U.S. laboratory practices.

Samimi G,  Trabert B,  Duggan MA,  Robinson JL,  Coa KI,  Waibel E,  Garcia E,  Minasian LM,  Sherman ME
Gynecol Oncol 2018 Mar;148(3):515-520
Major Program(s) or Research Group(s): Breast and Gynecologic Cancer ;  Office of the Director
PubMed ID: 29395311
PMC ID: PMC5829019

Estimating the number of potential family members eligible for BRCA1 and BRCA2 mutation testing in a "Traceback" approach.

Moss HA,  Samimi G,  Havrilesky LJ,  Sherman ME,  Myers ER
Genet Epidemiol 2018 Feb;42(1):117-122
Major Program(s) or Research Group(s): Breast and Gynecologic Cancer
PubMed ID: 29193313
PMC ID: not available

Ethnicity and breast cancer characteristics in Kenya.

Sayed S,  Moloo Z,  Wasike R,  Bird P,  Oigara R,  Njoroge FW,  Shaikh AJ,  Prasad SV,  Vinayak S,  Gierach GL,  Dawsey SM,  Palakal M,  Fan S,  Mullooly M,  Chauhan R,  Okiro P,  Gakinya S,  Nzioka A,  Kyobutungi C,  Mohamed S,  Haregu T,  Mussajee M,  Bonass B,  Mariwa C,  Sherman OA,  Mohammed A,  Gachii A,  Githaiga J,  Karanu J,  Nyagah R,  Njoroge R,  Muramba I,  Otieno JO,  Raburu DO,  Mwachiro EB,  Abayo I,  Saleh M
Breast Cancer Res Treat 2018 Jan;167(2):425-437
Major Program(s) or Research Group(s): Breast and Gynecologic CancerCancer Prevention Fellowship Program
PubMed ID: 28951987
PMC ID: PMC5792313

Mammographic Breast Density and Breast Cancer Molecular Subtypes: The Kenyan-African Aspect

Shaikh Asim Jamal,  Mullooly Maeve,  Sayed Shahin,  Ndumia Rose,  Abayo Innocent,  Orwa James,  Wasike Ronald,  Moloo Zahir,  Gierach Gretchen L.
Biomed Res Int 2018
Major Program(s) or Research Group(s): Breast and Gynecologic CancerCancer Prevention Fellowship Program
PubMed ID: not available
PMC ID: not available

Ovarian Cancer Prevention in High-risk Women.

Temkin SM,  Bergstrom J,  Samimi G,  Minasian L
Clin Obstet Gynecol 2017 Dec;60(4):738-757
Major Program(s) or Research Group(s): Breast and Gynecologic Cancer ;  Office of the Director
PubMed ID: 28957949
PMC ID: PMC5920567

Outcomes from ovarian cancer screening in the PLCO trial: Histologic heterogeneity impacts detection, overdiagnosis and survival.

Temkin SM,  Miller EA,  Samimi G,  Berg CD,  Pinsky P,  Minasian L
Eur J Cancer 2017 Dec;87:182-188
Major Program(s) or Research Group(s): Breast and Gynecologic CancerEarly Detection ;  Office of the Director ;  Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 29156299
PMC ID: not available

Association analysis identifies 65 new breast cancer risk loci.

Michailidou K,  Lindström S,  Dennis J,  Beesley J,  Hui S,  Kar S,  Lemaçon A,  Soucy P,  Glubb D,  Rostamianfar A,  Bolla MK,  Wang Q,  Tyrer J,  Dicks E,  Lee A,  Wang Z,  Allen J,  Keeman R,  Eilber U,  French JD,  Qing Chen X,  Fachal L,  McCue K,  McCart Reed AE,  Ghoussaini M,  Carroll JS,  Jiang X,  Finucane H,  Adams M,  Adank MA,  Ahsan H,  Aittomäki K,  Anton-Culver H,  Antonenkova NN,  Arndt V,  Aronson KJ,  Arun B,  Auer PL,  Bacot F,  Barrdahl M,  Baynes C,  Beckmann MW,  Behrens S,  Benitez J,  Bermisheva M,  Bernstein L,  Blomqvist C,  Bogdanova NV,  Bojesen SE,  Bonanni B,  Børresen-Dale AL,  Brand JS,  Brauch H,  Brennan P,  Brenner H,  Brinton L,  Broberg P,  Brock IW,  Broeks A,  Brooks-Wilson A,  Brucker SY,  Brüning T,  Burwinkel B,  Butterbach K,  Cai Q,  Cai H,  Caldés T,  Canzian F,  Carracedo A,  Carter BD,  Castelao JE,  Chan TL,  David Cheng TY,  Seng Chia K,  Choi JY,  Christiansen H,  Clarke CL,  NBCS Collaborators,  Collée M,  Conroy DM,  Cordina-Duverger E,  Cornelissen S,  Cox DG,  Cox A,  Cross SS,  Cunningham JM,  Czene K,  Daly MB,  Devilee P,  Doheny KF,  Dörk T,  Dos-Santos-Silva I,  Dumont M,  Durcan L,  Dwek M,  Eccles DM,  Ekici AB,  Eliassen AH,  Ellberg C,  Elvira M,  Engel C,  Eriksson M,  Fasching PA,  Figueroa J,  Flesch-Janys D,  Fletcher O,  Flyger H,  Fritschi L,  Gaborieau V,  Gabrielson M,  Gago-Dominguez M,  Gao YT,  Gapstur SM,  García-Sáenz JA,  Gaudet MM,  Georgoulias V,  Giles GG,  Glendon G,  Goldberg MS,  Goldgar DE,  González-Neira A,  Grenaker Alnæs GI,  Grip M,  Gronwald J,  Grundy A,  Guénel P,  Haeberle L,  Hahnen E,  Haiman CA,  HÃ¥kansson N,  Hamann U,  Hamel N,  Hankinson S,  Harrington P,  Hart SN,  Hartikainen JM,  Hartman M,  Hein A,  Heyworth J,  Hicks B,  Hillemanns P,  Ho DN,  Hollestelle A,  Hooning MJ,  Hoover RN,  Hopper JL,  Hou MF,  Hsiung CN,  Huang G,  Humphreys K,  Ishiguro J,  Ito H,  Iwasaki M,  Iwata H,  Jakubowska A,  Janni W,  John EM,  Johnson N,  Jones K,  Jones M,  Jukkola-Vuorinen A,  Kaaks R,  Kabisch M,  Kaczmarek K,  Kang D,  Kasuga Y,  Kerin MJ,  Khan S,  Khusnutdinova E,  Kiiski JI,  Kim SW,  Knight JA,  Kosma VM,  Kristensen VN,  Krüger U,  Kwong A,  Lambrechts D,  Le Marchand L,  Lee E,  Lee MH,  Lee JW,  Neng Lee C,  Lejbkowicz F,  Li J,  Lilyquist J,  Lindblom A,  Lissowska J,  Lo WY,  Loibl S,  Long J,  Lophatananon A,  Lubinski J,  Luccarini C,  Lux MP,  Ma ESK,  MacInnis RJ,  Maishman T,  Makalic E,  Malone KE,  Kostovska IM,  Mannermaa A,  Manoukian S,  Manson JE,  Margolin S,  Mariapun S,  Martinez ME,  Matsuo K,  Mavroudis D,  McKay J,  McLean C,  Meijers-Heijboer H,  Meindl A,  Menéndez P,  Menon U,  Meyer J,  Miao H,  Miller N,  Taib NAM,  Muir K,  Mulligan AM,  Mulot C,  Neuhausen SL,  Nevanlinna H,  Neven P,  Nielsen SF,  Noh DY,  Nordestgaard BG,  Norman A,  Olopade OI,  Olson JE,  Olsson H,  Olswold C,  Orr N,  Pankratz VS,  Park SK,  Park-Simon TW,  Lloyd R,  Perez JIA,  Peterlongo P,  Peto J,  Phillips KA,  Pinchev M,  Plaseska-Karanfilska D,  Prentice R,  Presneau N,  Prokofyeva D,  Pugh E,  Pylkäs K,  Rack B,  Radice P,  Rahman N,  Rennert G,  Rennert HS,  Rhenius V,  Romero A,  Romm J,  Ruddy KJ,  Rüdiger T,  Rudolph A,  Ruebner M,  Rutgers EJT,  Saloustros E,  Sandler DP,  Sangrajrang S,  Sawyer EJ,  Schmidt DF,  Schmutzler RK,  Schneeweiss A,  Schoemaker MJ,  Schumacher F,  Schürmann P,  Scott RJ,  Scott C,  Seal S,  Seynaeve C,  Shah M,  Sharma P,  Shen CY,  Sheng G,  Sherman ME,  Shrubsole MJ,  Shu XO,  Smeets A,  Sohn C,  Southey MC,  Spinelli JJ,  Stegmaier C,  Stewart-Brown S,  Stone J,  Stram DO,  Surowy H,  Swerdlow A,  Tamimi R,  Taylor JA,  Tengström M,  Teo SH,  Beth Terry M,  Tessier DC,  Thanasitthichai S,  Thöne K,  Tollenaar RAEM,  Tomlinson I,  Tong L,  Torres D,  Truong T,  Tseng CC,  Tsugane S,  Ulmer HU,  Ursin G,  Untch M,  Vachon C,  van Asperen CJ,  Van Den Berg D,  van den Ouweland AMW,  van der Kolk L,  van der Luijt RB,  Vincent D,  Vollenweider J,  Waisfisz Q,  Wang-Gohrke S,  Weinberg CR,  Wendt C,  Whittemore AS,  Wildiers H,  Willett W,  Winqvist R,  Wolk A,  Wu AH,  Xia L,  Yamaji T,  Yang XR,  Har Yip C,  Yoo KY,  Yu JC,  Zheng W,  Zheng Y,  Zhu B,  Ziogas A,  Ziv E,  ABCTB Investigators,  ConFab/AOCS Investigators,  Lakhani SR,  Antoniou AC,  Droit A,  Andrulis IL,  Amos CI,  Couch FJ,  Pharoah PDP,  Chang-Claude J,  Hall P,  Hunter DJ,  Milne RL,  García-Closas M,  Schmidt MK,  Chanock SJ,  Dunning AM,  Edwards SL,  Bader GD,  Chenevix-Trench G,  Simard J,  Kraft P,  Easton DF
Nature 2017 Nov 2;551(7678):92-94
Major Program(s) or Research Group(s): Breast and Gynecologic Cancer
PubMed ID: 29059683
PMC ID: PMC5798588

Traceback: leveraging archived biospecimens to identify mutation carriers.

Samimi G,  Sherman ME
Oncotarget 2017 Oct 31;8(53):90628-90629
Major Program(s) or Research Group(s): Breast and Gynecologic Cancer
PubMed ID: 29207588
PMC ID: PMC5710869

Functional prediction of long non-coding RNAs in ovarian cancer-associated fibroblasts indicate a potential role in metastasis.

Vafaee F,  Colvin EK,  Mok SC,  Howell VM,  Samimi G
Sci Rep 2017 Sep 4;7(1):10374
Major Program(s) or Research Group(s): Breast and Gynecologic Cancer
PubMed ID: 28871211
PMC ID: PMC5583324

Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study.

Aroda VR,  Knowler WC,  Crandall JP,  Perreault L,  Edelstein SL,  Jeffries SL,  Molitch ME,  Pi-Sunyer X,  Darwin C,  Heckman-Stoddard BM,  Temprosa M,  Kahn SE,  Nathan DM,  Diabetes Prevention Program Research Group
Diabetologia 2017 Sep;60(9):1601-1611
Major Program(s) or Research Group(s): Breast and Gynecologic Cancer
PubMed ID: 28770322
PMC ID: PMC5709233

Repurposing metformin for the prevention of cancer and cancer recurrence.

Heckman-Stoddard BM,  DeCensi A,  Sahasrabuddhe VV,  Ford LG
Diabetologia 2017 Sep;60(9):1639-1647
Major Program(s) or Research Group(s): Breast and Gynecologic Cancer ;  Office of the Director
PubMed ID: 28776080
PMC ID: PMC5709147

Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials.

Skates SJ,  Greene MH,  Buys SS,  Mai PL,  Brown P,  Piedmonte M,  Rodriguez G,  Schorge JO,  Sherman M,  Daly MB,  Rutherford T,  Brewster WR,  O'Malley DM,  Partridge E,  Boggess J,  Drescher CW,  Isaacs C,  Berchuck A,  Domchek S,  Davidson SA,  Edwards R,  Elg SA,  Wakeley K,  Phillips KA,  Armstrong D,  Horowitz I,  Fabian CJ,  Walker J,  Sluss PM,  Welch W,  Minasian L,  Horick NK,  Kasten CH,  Nayfield S,  Alberts D,  Finkelstein DM,  Lu KH
Clin Cancer Res 2017 Jul 15;23(14):3628-3637
Major Program(s) or Research Group(s): Breast and Gynecologic CancerEarly Detection ;  Office of the Director ;  NCI Community Oncology Research Program
PubMed ID: 28143870
PMC ID: PMC5726402

Traceback: A Proposed Framework to Increase Identification and Genetic Counseling of BRCA1 and BRCA2 Mutation Carriers Through Family-Based Outreach.

Samimi G,  Bernardini MQ,  Brody LC,  Caga-Anan CF,  Campbell IG,  Chenevix-Trench G,  Couch FJ,  Dean M,  de Hullu JA,  Domchek SM,  Drapkin R,  Spencer Feigelson H,  Friedlander M,  Gaudet MM,  Harmsen MG,  Hurley K,  James PA,  Kwon JS,  Lacbawan F,  Lheureux S,  Mai PL,  Mechanic LE,  Minasian LM,  Myers ER,  Robson ME,  Ramus SJ,  Rezende LF,  Shaw PA,  Slavin TP,  Swisher EM,  Takenaka M,  Bowtell DD,  Sherman ME
J Clin Oncol 2017 Jul 10;35(20):2329-2337
Major Program(s) or Research Group(s): Breast and Gynecologic Cancer ;  Office of the Director
PubMed ID: 28398847
PMC ID: PMC5501360

Tissue-based Immunohistochemical Biomarker Accuracy in the Diagnosis of Malignant Glandular Lesions of the Uterine Cervix: A Systematic Review of the Literature and Meta-Analysis.

Lee S,  Rose MS,  Sahasrabuddhe VV,  Zhao R,  Duggan MA
Int J Gynecol Pathol 2017 Jul;36(4):310-322
Major Program(s) or Research Group(s): Breast and Gynecologic Cancer
PubMed ID: 27801764
PMC ID: PMC5512892

Opportunistic salpingectomy: What about the role of the ovary in ovarian cancer?

Samimi G,  Minasian LM
Cancer 2017 May 15;123(10):1699-1702
Major Program(s) or Research Group(s): Breast and Gynecologic Cancer ;  Office of the Director
PubMed ID: 28334415
PMC ID: not available

Rates and determinants of incidence and clearance of cervical HPV genotypes among HIV-seropositive women in Pune, India.

Mane A,  Sahasrabuddhe VV,  Nirmalkar A,  Risbud AR,  Sahay S,  Bhosale RA,  Vermund SH,  Mehendale SM
J Clin Virol 2017 Mar;88:26-32
Major Program(s) or Research Group(s): Breast and Gynecologic Cancer
PubMed ID: 28152432
PMC ID: PMC5441893

Ultrasound tomography imaging with waveform sound speed: Parenchymal changes in women undergoing tamoxifen therapy.

Sak M,  Duric N,  Littrup P,  Sherman M,  Gierach G
Proc SPIE Int Soc Opt Eng 2017 Mar;10139
Major Program(s) or Research Group(s): Breast and Gynecologic Cancer
PubMed ID: 29046597
PMC ID: PMC5642114

Prediagnostic circulating inflammation markers and endometrial cancer risk in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial.

Trabert B,  Eldridge RC,  Pfeiffer RM,  Shiels MS,  Kemp TJ,  Guillemette C,  Hartge P,  Sherman ME,  Brinton LA,  Black A,  Chaturvedi AK,  Hildesheim A,  Berndt SI,  Safaeian M,  Pinto L,  Wentzensen N
Int J Cancer 2017 Feb 1;140(3):600-610
Major Program(s) or Research Group(s): Breast and Gynecologic CancerProstate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 27770434
PMC ID: PMC5159268

Using Speed of Sound Imaging to Characterize Breast Density.

Sak M,  Duric N,  Littrup P,  Bey-Knight L,  Ali H,  Vallieres P,  Sherman ME,  Gierach GL
Ultrasound Med Biol 2017 Jan;43(1):91-103
Major Program(s) or Research Group(s): Breast and Gynecologic Cancer
PubMed ID: 27692872
PMC ID: PMC5761326

The Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial Pathology Tissue Resource.

Zhu CS,  Huang WY,  Pinsky PF,  Berg CD,  Sherman M,  Yu KJ,  Carrick DM,  Black A,  Hoover R,  Lenz P,  Williams C,  Hawkins L,  Chaloux M,  Yurgalevitch S,  Mathew S,  Miller A,  Olivo V,  Khan A,  Pretzel SM,  Multerer D,  Beckmann P,  Broski KG,  Freedman ND
Cancer Epidemiol Biomarkers Prev 2016 Dec;25(12):1635-1642
Major Program(s) or Research Group(s): Breast and Gynecologic CancerBiometryEarly DetectionProstate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 27635065
PMC ID: PMC5135604

Body Mass Index, Waist Circumference, Diabetes, and Risk of Liver Cancer for U.S. Adults.

Campbell PT,  Newton CC,  Freedman ND,  Koshiol J,  Alavanja MC,  Beane Freeman LE,  Buring JE,  Chan AT,  Chong DQ,  Datta M,  Gaudet MM,  Gaziano JM,  Giovannucci EL,  Graubard BI,  Hollenbeck AR,  King L,  Lee IM,  Linet MS,  Palmer JR,  Petrick JL,  Poynter JN,  Purdue MP,  Robien K,  Rosenberg L,  Sahasrabuddhe VV,  Schairer C,  Sesso HD,  Sigurdson AJ,  Stevens VL,  Wactawski-Wende J,  Zeleniuch-Jacquotte A,  Renehan AG,  McGlynn KA
Cancer Res 2016 Oct 15;76(20):6076-6083
Major Program(s) or Research Group(s): Breast and Gynecologic Cancer
PubMed ID: 27742674
PMC ID: PMC5141518

Rationale for Developing a Specimen Bank to Study the Pathogenesis of High-Grade Serous Carcinoma: A Review of the Evidence.

Sherman ME,  Drapkin RI,  Horowitz NS,  Crum CP,  Friedman S,  Kwon JS,  Levine DA,  Shih IeM,  Shoupe D,  Swisher EM,  Walker J,  Trabert B,  Greene MH,  Samimi G,  Temkin SM,  Minasian LM
Cancer Prev Res (Phila) 2016 Sep;9(9):713-20
Major Program(s) or Research Group(s): Breast and Gynecologic Cancer ;  Office of the Director
PubMed ID: 27221539
PMC ID: PMC5010984

The ADAMs family of proteases as targets for the treatment of cancer.

Mullooly M,  McGowan PM,  Crown J,  Duffy MJ
Cancer Biol Ther 2016 Aug 2;17(8):870-80
Major Program(s) or Research Group(s): Breast and Gynecologic Cancer
PubMed ID: 27115328
PMC ID: PMC5004698

Associations of NSAID and paracetamol use with risk of primary liver cancer in the Clinical Practice Research Datalink.

Yang B,  Petrick JL,  Chen J,  Hagberg KW,  Sahasrabuddhe VV,  Graubard BI,  Jick S,  McGlynn KA
Cancer Epidemiol 2016 Aug;43:105-11
Major Program(s) or Research Group(s): Breast and Gynecologic Cancer
PubMed ID: 27420633
PMC ID: PMC5031234

Phase I biomarker modulation study of atorvastatin in women at increased risk for breast cancer.

Arun BK,  Gong Y,  Liu D,  Litton JK,  Gutierrez-Barrera AM,  Jack Lee J,  Vornik L,  Ibrahim NK,  Cornelison T,  Hortobagyi GN,  Heckman-Stoddard BM,  Koenig KB,  Alvarez RR,  Murray JL,  Valero V,  Lippman SM,  Brown P,  Sneige N
Breast Cancer Res Treat 2016 Jul;158(1):67-77
Major Program(s) or Research Group(s): Breast and Gynecologic Cancer
PubMed ID: 27287781
PMC ID: PMC5989315

Associations of antibiotic use with risk of primary liver cancer in the Clinical Practice Research Datalink.

Yang B,  Hagberg KW,  Chen J,  Sahasrabuddhe VV,  Graubard BI,  Jick S,  McGlynn KA
Br J Cancer 2016 Jun 28;115(1):85-9
Major Program(s) or Research Group(s): Breast and Gynecologic Cancer
PubMed ID: 27219020
PMC ID: PMC4931369

Mammographic Density as a Biosensor of Tamoxifen Effectiveness in Adjuvant Endocrine Treatment of Breast Cancer: Opportunities and Implications.

Mullooly M,  Pfeiffer RM,  Nyante SJ,  Heckman-Stoddard BM,  Perloff M,  Jatoi I,  Brinton LA,  Aiello Bowles EJ,  Hoover RN,  Glass A,  Berrington de Gonzalez A,  Sherman ME,  Gierach GL
J Clin Oncol 2016 Jun 20;34(18):2093-7
Major Program(s) or Research Group(s): Breast and Gynecologic CancerChemopreventive Agent Development
PubMed ID: 27022110
PMC ID: PMC4962703

Insulin/IGF and sex hormone axes in human endometrium and associations with endometrial cancer risk factors.

Merritt MA,  Strickler HD,  Einstein MH,  Yang HP,  Sherman ME,  Wentzensen N,  Brouwer-Visser J,  Cossio MJ,  Whitney KD,  Yu H,  Gunter MJ,  Huang GS
Cancer Causes Control 2016 Jun;27(6):737-48
Major Program(s) or Research Group(s): Breast and Gynecologic Cancer
PubMed ID: 27125830
PMC ID: PMC4870288